Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Ginkgo Bioworks Holdings Inc (NYSE: DNA) closed the day trading at $8.58 up 0.35% from the previous closing price of $8.55. In other words, the price has increased by $0.35 from its previous closing price. On the day, 0.9 million shares were traded. DNA stock price reached its highest trading level at $9.01 during the session, while it also had its lowest trading level at $8.33.
Ratios:
For a better understanding of DNA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.88 and its Current Ratio is at 4.88. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.67.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 18 ’25 when Che Austin bought 99 shares for $8.46 per share.
Che Austin bought 99 shares of DNA for $897 on Jun 17 ’25. On Jun 16 ’25, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $9.04 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNA now has a Market Capitalization of 502203712 and an Enterprise Value of 419842496. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.12 while its Price-to-Book (P/B) ratio in mrq is 0.69. Its current Enterprise Value per Revenue stands at 1.768 whereas that against EBITDA is -1.291.
Stock Price History:
The Beta on a monthly basis for DNA is 1.27, which has changed by -0.47555012 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, DNA has reached a high of $18.40, while it has fallen to a 52-week low of $5.00. The 50-Day Moving Average of the stock is 11.40%, while the 200-Day Moving Average is calculated to be -0.20%.
Shares Statistics:
Over the past 3-months, DNA traded about 1.22M shares per day on average, while over the past 10 days, DNA traded about 1184050 shares per day. A total of 43.08M shares are outstanding, with a floating share count of 37.41M. Insiders hold about 32.63% of the company’s shares, while institutions hold 57.97% stake in the company. Shares short for DNA as of 1748563200 were 11816777 with a Short Ratio of 9.67, compared to 1745971200 on 11631391. Therefore, it implies a Short% of Shares Outstanding of 11816777 and a Short% of Float of 26.179999999999996.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
